|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01875 BIODLINK-B
Nominal 
4.050 +0.090 (+2.273%) | 2026/06 - Interim RMB(K¥) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 16,142 | 116,403 | 56,431 | 59,929 |
| Net Cash from / (used in) Investing Activities | -- | (43,070) | (122,505) | (164,105) | (282,764) |
| Net Cash from / (used in) Financing Activities | -- | (25,662) | 34,183 | 38,225 | 481,240 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (52,590) | 28,081 | (69,449) | 258,405 |
| Cash & Cash Equivalents at beginning of period | -- | 381,256 | 351,600 | 417,769 | 152,805 |
| Effect of Foreign Exchange Rate Changes | -- | (1,111) | 1,575 | 3,280 | 6,559 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 327,555 | 381,256 | 351,600 | 417,769 |
| Remarks: | Real time quote last updated: 25/08/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -58,517 |
| %Change | -- |
| EPS / (LPS) | RMB -0.080 |
| NBV Per Share (¥) | RMB 0.795 |